ijms-logo

Journal Browser

Journal Browser

Stem Cells in Tissue Engineering

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 20 October 2025 | Viewed by 2216

Special Issue Editor


E-Mail Website
Guest Editor
Department of Urology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8655, Japan
Interests: nucelar receptor; transcriptional factors; transcriptional coregulators; cancer

Special Issue Information

Dear Colleagues,

Pluripotent stem cells are powerful tools for tissue engineering, disease modeling, and drug screening systems. Recent studies have revealed the mechanisms involved in stem cell maintenance and differentiation, leading to new approaches for therapy. For example, the establishment of differentiated immune cells such as T and NK cells from induced pluripotent stem cells (iPS cells) is expected to be applied to CAR-T/NK therapy for cancer treatment.

In particular, transcription factors (TFs) appear to play pivotal roles for stem cell maintenance and differentiation as the master regulators. After binding to specific DNA elements, TFs regulate their target genes by associating with numerous transcriptional co-regulators, which are involved in RNA polymerase subunits, histone modifiers and binding proteins, chromatin remodeling factors, and others (such as lncRNAs). In recent years, with the development of PROTAC, targeting TFs and transcriptional co-regulators such as chromatin remodeling factors have  become  attractive drug targets for novel therapy.

Besides iPS inducible four TFs (Oct4, Sox2, Klf4 and c-Myc), nuclear receptors (NRs) and their transcriptional co-regulators involved in stem cell maintenance and differentiation are a good target for stem cell engineering. NRs are DNA-bound transcription factors that consist of two C4-type Zn Fingers in the DNA binding domain, and its transcriptional activity is regulated by direct binding with lipid-soluble ligands. There are many NRs acting as master regulators of stem cell maintenance (e.g., TLX; neural stem cells, ERRβ and LRH1; iPS cells) and differentiation (e.g., RORγt; Th17 differentiation, PPARγ; adipogenesis). In addition, NRs’ transcriptional co-regulators also regulate stem cell maintenance and differentiation. Furthermore, gene mutation diseases related to NRs have been reported, and drug discovery by creating mutated iPS can be expected.

This Special Issue aims to gain insight into the roles of TFs (not limited to NRs) and transcriptional co-regulators in stem cells including iPS, embryonic stem cells (ESs), and mesenchymal stem cells (MSCs) for tissue engineering and drug screening. I invite researchers to contribute original research and review articles covering, but not limited to, the following research areas:

  1. Molecular mechanisms of stem cell maintenance and differentiation through TFs network.
  2. Application of stem cells for genetic disease modeling and drug screening.
  3. Application of stem cells for cancer immunotherapy.

Dr. Ichiro Takada
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • stem cells
  • transcription factors
  • transcription co-regulators
  • chromatin remodeling factors
  • chromatin receptors
  • nuclear maintenance and differentiation
  • iPS cells
  • iPS-T/NK
  • tissue engineering

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

24 pages, 6293 KB  
Article
Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Enhance Chondrocyte Function by Reducing Oxidative Stress in Chondrocytes
by Che-Wei Wu, Yao-Hui Huang, Pei-Lin Shao, Ling-Hua Chang, Cheng-Chang Lu, Chung-Hwan Chen, Yin-Chih Fu, Mei-Ling Ho, Je-Ken Chang and Shun-Cheng Wu
Int. J. Mol. Sci. 2025, 26(16), 7683; https://doi.org/10.3390/ijms26167683 - 8 Aug 2025
Viewed by 726
Abstract
Articular cartilage (AC) has a very limited capacity for self-healing once damaged. Chondrocytes maintain AC homeostasis and are key cells in AC tissue engineering (ACTE). However, chondrocytes lose their function due to oxidative stress. Umbilical cord mesenchymal stem cells (UCMSCs) are investigated as [...] Read more.
Articular cartilage (AC) has a very limited capacity for self-healing once damaged. Chondrocytes maintain AC homeostasis and are key cells in AC tissue engineering (ACTE). However, chondrocytes lose their function due to oxidative stress. Umbilical cord mesenchymal stem cells (UCMSCs) are investigated as an alternative cell source for ACTE. MSCs are known to regulate tissue regeneration through host cell modulation, largely via extracellular vesicle (EV)-mediated cell-to-cell communication. The purpose of this study was to verify whether UCMSC-derived EVs (UCMSC-EVs) enhance chondrocyte function. The mean particle sizes of the UCMSC-EVs were 79.8 ± 19.05 nm. Transmission electron microscopy (TEM) revealed that UCMSC-EVs exhibited a spherical morphology. The presence of CD9, CD63, and CD81 confirmed the identity of UCMSC-EVs, with α-tubulin undetected. UCMSC-EVs maintained chondrocyte survival, and increased chondrocyte proliferation after intake by chondrocytes. UCMSC-EVs upregulated mRNA levels of SOX-9, collagen type II (Col-II), and Aggrecan, while decreasing collagen type I (Col-I) levels. UCMSC-EVs reduced the oxidative stress of chondrocytes by reducing mitochondrial superoxide production and increasing protein levels of SOD-2 and Sirt-3 in chondrocytes. The 50 most abundant known microRNAs (miRNAs) derived from UCMSC-EVs were selected for gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. GO analysis revealed enrichment in pathways associated with small GTPase-mediated signal transduction, GTPase regulatory activity, and mitochondrial matrix. The KEGG analysis indicated that these miRNAs may regulate chondrocyte function through the PI3K-Akt, MAPK, and cAMP signaling pathways. In summary, this study shows that UCMSC-EVs enhance chondrocyte function and may be applied to ACTE. Full article
(This article belongs to the Special Issue Stem Cells in Tissue Engineering)
Show Figures

Figure 1

Review

Jump to: Research

14 pages, 1350 KB  
Review
The Role of ESS2/DGCR14: Is It an Essential Factor in Splicing and Transcription?
by Ichiro Takada, Shinya Hidano, Tohru Nakagawa, Shinichi Nakagawa, Makoto Makishima and Sayuri Takahashi
Int. J. Mol. Sci. 2025, 26(9), 4056; https://doi.org/10.3390/ijms26094056 - 25 Apr 2025
Viewed by 905
Abstract
ESS2 (ess-2 splicing factor homolog, also known as DGCR14 or DGS-I) is a member of the deletion gene cluster in the 22q11.2 deletion syndrome (22q11.2DS, also known as DiGeorge syndrome or CATCH 22 syndrome). The ESS2 gene is not part of a gene [...] Read more.
ESS2 (ess-2 splicing factor homolog, also known as DGCR14 or DGS-I) is a member of the deletion gene cluster in the 22q11.2 deletion syndrome (22q11.2DS, also known as DiGeorge syndrome or CATCH 22 syndrome). The ESS2 gene is not part of a gene family, and the coded protein has a coiled-coil structure (Es domain), which is conserved from yeast to humans. Recent studies have shown that ESS2 is involved in splicing C and C* complex, but other interactants, such as transcription factors and U1 snRNP, are also reported. Although the molecular mechanism is still under investigation, ESS2 plays a pivotal role in cell differentiation and proliferation. ESS2 knockout mice show embryonic lethal in the early stage, and recent studies show the association of ESS2 with cancer, autoimmune disease, and neurodevelopmental disorders. ESS2 can regulate mRNA splicing and transcriptional activity through interactions with other proteins, and ESS2-dependent gene expression regulation seems to be cell type-selective. In this review, we summarized the cloning history and functions of ESS2, including recent findings. Full article
(This article belongs to the Special Issue Stem Cells in Tissue Engineering)
Show Figures

Figure 1

Back to TopTop